speb/financial-data huggingface dataset:
Financial ratios for MOTR.L — annual report dated 2024-03-31
Total revenue: 1375443037.9746835
Gross profit: 92531645.56962025
Operating income: 253164.5569620253
Net income: -10632911.392405063
Capital expenditures: 3291139.240506329
Operating cash flow: 14050632.911392404
Depreciation & amortization: 12531645.569620254
Net tangible assets: 34683544.30379747
Owner earnings: -1392405.0632911385
Return on net tangible assets (%): -4.014598540145983
Capex to operating income (%): 1300.0000000000002
Buffett classification: The Gruesome
Stock price: 0.01658227848101266
Shares outstanding: 79632232
Book value: 39367088.60759491
P/B ratio: 0.03354283727331193
Market cap (USD): 1320483.8470886077
Debt to equity: 1.9163987138263678
Current ratio: 1.1732629727352684
Quick ratio: 0.27264731750219884
Interest coverage ratio: 0.020618556701030927
COGS to revenue (%): 93.27259341063868
SG&A to revenue (%): 6.709000552181116
Free cash flow (dilution-adjusted): 9493670.88607595
Buyback yield (%): 28.758158328123496
Retained earnings: 45569620.25316455
Inventory turnover: 9.8974609375
Receivables turnover: 56.59375
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.2306805074971165
FCF margin (%): 0.6902263942573164
Revenue growth (%): -22.64207327041427
Rule of 40 score: -21.951846876156953
Financial ratios for MOTR.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 33733333.333333336
Buffett classification: The Gruesome
Stock price: 0.0192
Shares outstanding: 79632232
Book value: 37866666.66666669
P/B ratio: 0.04037690636619716
Market cap (USD): 1528938.8543999998
Debt to equity: 2.042253521126759
Current ratio: 1.1331923890063424
Quick ratio: 0.2219873150105708
Buyback yield (%): 0
Retained earnings: 43866666.666666664
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MOTR.L — annual report dated 2025-03-31
Total revenue: 1523506493.5064936
Gross profit: 117922077.92207792
Operating income: 16493506.493506493
Net income: 4155844.1558441557
Capital expenditures: 9480519.480519481
Operating cash flow: 25194805.194805194
Depreciation & amortization: 13506493.506493507
Net tangible assets: 31038961.038961038
Owner earnings: 8181818.18181818
Return on net tangible assets (%): 26.35983263598326
Capex to operating income (%): 57.48031496062993
Buffett classification: The Good
Stock price: 0.01584415584415584
P/E ratio: 0.30359788449999997
Shares outstanding: 79632232
Book value: 34935064.93506491
P/B ratio: 0.03611573347211897
Market cap (USD): 1261705.4940259738
Debt to equity: 2.133828996282529
Current ratio: 1.059987631416203
Quick ratio: 0.12368583797155236
Effective tax rate (%): 21.951219512195124
Interest coverage ratio: 1.351063829787234
COGS to revenue (%): 92.25982439689709
SG&A to revenue (%): 6.657573949364931
Free cash flow (dilution-adjusted): 14025974.025974024
Buyback yield (%): 874.9237513214622
Retained earnings: 45714285.71428572
Inventory turnover: 7.148612945838837
Receivables turnover: 87.544776119403
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.796019900497516
FCF margin (%): 0.9206376268007841
Revenue growth (%): 10.764782796809309
Rule of 40 score: 11.685420423610093
Financial ratios for MOTR.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 31038961.038961038
Buffett classification: The Gruesome
Stock price: 0.01584415584415584
Shares outstanding: 79632232
Book value: 34935064.93506491
P/B ratio: 0.03611573347211897
Market cap (USD): 1261705.4940259738
Debt to equity: 2.133828996282529
Current ratio: 1.059987631416203
Quick ratio: 0.12368583797155236
Buyback yield (%): 0
Retained earnings: 45714285.71428572
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MOTR.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 29864864.864864863
Buffett classification: The Gruesome
Stock price: 0.021216216216216218
Shares outstanding: 79632232
Book value: 32837837.837837875
P/B ratio: 0.05144963137448554
Market cap (USD): 1689494.651891892
Debt to equity: 2.2633744855967053
Current ratio: 1.058280718795532
Quick ratio: 0.15055852355512397
Buyback yield (%): 0
Retained earnings: 42972972.972972974
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NARF.L — annual report dated 2021-12-31
Total revenue: 2620967.567567568
Gross profit: 1703628.3783783785
Operating income: -1243790.5405405406
Net income: -1138741.8918918918
Capital expenditures: 0
Operating cash flow: -574000
Depreciation & amortization: 428428.3783783784
Net tangible assets: -1401987.8378378379
Owner earnings: -710313.5135135134
Buffett classification: The Gruesome
Stock price: 0.0002702702702702703
Shares outstanding: 1697381000
Book value: -1401987.8378378379
Market cap (USD): 458751.62162162166
Debt to equity: -0.8022508580962745
Current ratio: 0.3173526302054781
Quick ratio: 0.3173526302054781
Interest coverage ratio: -1200.0065189048241
COGS to revenue (%): 35.00002062370199
SG&A to revenue (%): 110.01254952266439
Free cash flow (dilution-adjusted): -574000
Buyback yield (%): 0
Retained earnings: 0
Receivables turnover: 40.34438573865291
Capitalized R&D asset: 0
FCF margin (%): -21.900309149292916
Rule of 40 score: -21.900309149292916
Financial ratios for NARF.L — annual report dated 2022-12-31
Total revenue: 3043237.3493975904
Gross profit: 907361.4457831326
Operating income: -22501179.51807229
Net income: -22510408.433734942
Capital expenditures: 602409.638554217
Operating cash flow: -3605796.3855421687
Depreciation & amortization: 397589.15662650607
Net tangible assets: -1914475.903614458
Owner earnings: -22715228.91566265
Buffett classification: The Gruesome
Stock price: 0.00012048192771084338
Shares outstanding: 1697381000
Book value: 38130.12048192741
P/B ratio: 5.363312057634016
Market cap (USD): 204503.73493975904
Debt to equity: 47.884668857432125
Current ratio: 0.42354505420541394
Quick ratio: 0.42354505420541394
Interest coverage ratio: -5841.720050046918
COGS to revenue (%): 70.18433524540093
SG&A to revenue (%): 130.78902579569078
Free cash flow (dilution-adjusted): -23302991.56626506
Buyback yield (%): 0
Retained earnings: -22927962.65060241
Receivables turnover: 3.9428664641551494
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -55957.98951310892
FCF margin (%): -765.7303355217396
Revenue growth (%): 16.111217363209
Rule of 40 score: -749.6191181585306
Financial ratios for NARF.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -3423634.6666666665
Buffett classification: The Gruesome
Stock price: 0.00013333333333333334
Shares outstanding: 1697381000
Book value: -2011965.3333333335
Market cap (USD): 226317.46666666667
Debt to equity: 0
Current ratio: 0.18319514217739874
Quick ratio: 0.18319514217739874
Buyback yield (%): 0
Retained earnings: -29804469.333333332
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NARF.L — annual report dated 2025-03-31
Total revenue: 3893993.5064935065
Gross profit: 539088.3116883116
Operating income: -4482615.584415584
Net income: -4624428.571428571
Capital expenditures: 0
Operating cash flow: -2411793.5064935065
Depreciation & amortization: 1628319.4805194805
Net tangible assets: -3880874.025974026
Owner earnings: -2996109.0909090904
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 1697381000
Book value: -3880874.0259740264
Market cap (USD): 0
Debt to equity: -1.03532575504313
Current ratio: 0.2366982295979749
Quick ratio: 0.2366982295979749
Interest coverage ratio: -31.608765728310036
COGS to revenue (%): 86.15590111310293
Free cash flow (dilution-adjusted): -3465276.6233766233
Retained earnings: -30833925.974025972
Receivables turnover: 11.652274785190482
Capitalized R&D asset: 0
FCF margin (%): -88.99030308083546
Revenue growth (%): 27.955629463614578
Rule of 40 score: -61.03467361722088
Financial ratios for NARF.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: -3880874.025974026
Buffett classification: The Gruesome
Stock price: 0
Shares outstanding: 1697381000
Book value: -3880874.0259740264
Market cap (USD): 0
Debt to equity: -1.03532575504313
Current ratio: 0.2366982295979749
Quick ratio: 0.2366982295979749
Retained earnings: -30833925.974025972
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NEWGEN.NS — annual report dated 2022-03-31
Total revenue: 102724713.17420547
Gross profit: 49561875.24726362
Operating income: 23378768.297507584
Net income: 21655637.610444415
Capital expenditures: 1659435.579585916
Operating cash flow: 18828010.02241857
Depreciation & amortization: 2324976.9220625083
Net tangible assets: 104504259.52789134
Owner earnings: 22321178.952921007
Return on net tangible assets (%): 21.359109239909657
Capex to operating income (%): 7.09804536521639
Buffett classification: The Great
Stock price: 2.9498879071607544
P/E ratio: 19.22846771221456
Shares outstanding: 141159509
Book value: 107002650.66596332
P/B ratio: 3.891536573984187
Market cap (USD): 416404728.57984966
Debt to equity: 0.03429056233717209
Current ratio: 3.125272979366424
Quick ratio: 3.125272979366424
Effective tax rate (%): 19.286412233551044
Interest coverage ratio: 85.6141401458444
COGS to revenue (%): 51.75272462117832
SG&A to revenue (%): 8.001255517763074
Free cash flow (dilution-adjusted): 16431399.182381643
Buyback yield (%): 0
Retained earnings: 79575656.07279441
Receivables turnover: 2.793195096212219
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.41855449867421
FCF margin (%): 15.995565891253932
Rule of 40 score: 15.995565891253932
Financial ratios for NEWGEN.NS — annual report dated 2023-03-31
Total revenue: 118633227.77101097
Gross profit: 55156735.68818514
Operating income: 23167953.71498173
Net income: 21560475.030450672
Capital expenditures: 2033179.0499390988
Operating cash flow: 16608319.123020707
Depreciation & amortization: 3005042.630937881
Net tangible assets: 117728160.77953716
Owner earnings: 22532338.611449454
Return on net tangible assets (%): 19.139293829319634
Capex to operating income (%): 8.775824895680486
Buffett classification: The Great
Stock price: 2.670158343483557
P/E ratio: 17.481907990712468
Shares outstanding: 141159509
Book value: 119674896.4677223
P/B ratio: 3.14951800121299
Market cap (USD): 376918240.71839225
Debt to equity: 0.04347242412426927
Current ratio: 2.791538486191256
Quick ratio: 2.791538486191256
Effective tax rate (%): 18.533186365090287
Interest coverage ratio: 55.90268919911829
COGS to revenue (%): 53.50650342697397
SG&A to revenue (%): 8.675897257722653
Free cash flow (dilution-adjusted): 12782423.873325214
Buyback yield (%): 0
Retained earnings: 91329244.82338612
Receivables turnover: 2.5091824163798044
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.144144957112854
FCF margin (%): 10.774741708957116
Revenue growth (%): 15.486550514701444
Rule of 40 score: 26.261292223658558
Financial ratios for NEWGEN.NS — annual report dated 2024-03-31
Total revenue: 149158004.5569013
Gross profit: 74108394.29188152
Operating income: 31219858.496222567
Net income: 30172082.98357117
Capital expenditures: 1634692.40916177
Operating cash flow: 33746336.49118599
Depreciation & amortization: 3353843.386497182
Net tangible assets: 145156697.44573689
Owner earnings: 31891233.960906584
Return on net tangible assets (%): 21.97021186213492
Capex to operating income (%): 5.236066042258196
Buffett classification: The Great
Stock price: 9.351967370441459
P/E ratio: 43.75299918518545
Shares outstanding: 141159509
Book value: 146722041.01211175
P/B ratio: 8.997415201486756
Market cap (USD): 1320119122.1955376
Debt to equity: 0.03964601662864643
Current ratio: 3.440611556183135
Quick ratio: 3.440611556183135
Effective tax rate (%): 17.29638172286358
Interest coverage ratio: 77.50592438225662
COGS to revenue (%): 50.31550970929596
SG&A to revenue (%): 8.814526374453845
Free cash flow (dilution-adjusted): 29167034.41659671
Buyback yield (%): 0
Retained earnings: 115894016.06907304
Receivables turnover: 2.8043622409581235
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.920779781842157
FCF margin (%): 19.554454689335813
Revenue growth (%): 25.73037702793528
Rule of 40 score: 45.28483171727109
Financial ratios for NEWGEN.NS — quarterly report dated 2024-09-30
Total revenue: 43138736.26373626
Gross profit: 21079347.826086957
Operating income: 8959340.65934066
Net income: 8400824.175824177
Capital expenditures: 0
Depreciation & amortization: 954730.0525561395
Net tangible assets: 153797503.58337316
Owner earnings: 9355554.228380317
Return on net tangible assets (%): 6.083033866221827
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.767200191113234
P/E ratio: 66.23428221743181
Shares outstanding: 141159509
Book value: 155132465.36072624
P/B ratio: 14.347030662517353
Market cap (USD): 2225690237.2822504
Debt to equity: 0.03331308338896293
Current ratio: 3.8934495556378996
Quick ratio: 3.8934495556378996
Effective tax rate (%): 24.027739520715524
Interest coverage ratio: 78.78949579831932
COGS to revenue (%): 51.13591715525775
Buyback yield (%): 0
Receivables turnover: 0.8175432560024176
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.435679956403017
Rule of 40 score: 0
Financial ratios for NEWGEN.NS — quarterly report dated 2024-12-31
Total revenue: 44423895.55892295
Gross profit: 22481151.64937638
Operating income: 11616563.702063177
Net income: 10374367.641916307
Capital expenditures: 0
Depreciation & amortization: 1009803.0073435132
Owner earnings: 11384170.64925982
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 19.521506003030655
P/E ratio: 66.40516071539925
Shares outstanding: 141159509
Market cap (USD): 2755646202.3283596
Effective tax rate (%): 16.53276214073433
Interest coverage ratio: 70.94646543745996
COGS to revenue (%): 49.394011113775825
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 2.979130606259849
Rule of 40 score: 2.979130606259849
Financial ratios for NEWGEN.NS — quarterly report dated 2025-03-31
Total revenue: 50255997.19429506
Gross profit: 27474456.39466916
Operating income: 15099660.97732055
Net income: 12665326.163198503
Capital expenditures: 0
Depreciation & amortization: 1010673.3691840074
Net tangible assets: 176188671.96633154
Owner earnings: 13675999.53238251
Return on net tangible assets (%): 7.762133274377539
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.44205858326526
P/E ratio: 31.881440532027092
Shares outstanding: 141159509
Book value: 177277542.67009586
P/B ratio: 9.110885379140653
Market cap (USD): 1615155371.5629597
Debt to equity: 0.03527015815610867
Current ratio: 3.811842393192603
Quick ratio: 3.811842393192603
Effective tax rate (%): 23.31119152382085
Interest coverage ratio: 98.80852203182373
COGS to revenue (%): 45.33098947683801
Buyback yield (%): 0
Retained earnings: 143274012.1580547
Receivables turnover: 0.7722389064593326
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.00872609341394
Revenue growth (%): 13.128298547425985
Rule of 40 score: 13.128298547425985
Financial ratios for NEWGEN.NS — annual report dated 2025-03-31
Total revenue: 173822679.44821134
Gross profit: 87099286.88332944
Operating income: 40187152.20949263
Net income: 36853214.87023614
Capital expenditures: 2699123.2172083235
Operating cash flow: 25131716.15618424
Depreciation & amortization: 3862672.4339490295
Net tangible assets: 176188671.96633154
Owner earnings: 38016764.08697685
Return on net tangible assets (%): 21.57730327534428
Capex to operating income (%): 6.716383393224767
Buffett classification: The Great
Stock price: 11.44205858326526
P/E ratio: 43.82671572209055
Shares outstanding: 141159509
Book value: 177277542.67009586
P/B ratio: 9.110885379140653
Market cap (USD): 1615155371.5629597
Debt to equity: 0.03527015815610867
Current ratio: 3.811842393192603
Quick ratio: 3.811842393192603
Effective tax rate (%): 21.57523026092382
Interest coverage ratio: 73.6656809171756
COGS to revenue (%): 49.891874202019906
SG&A to revenue (%): 8.18390626488016
Free cash flow (dilution-adjusted): 19433306.05564648
Buyback yield (%): 0
Retained earnings: 143274012.1580547
Receivables turnover: 2.670977463166438
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.314908659444193
FCF margin (%): 11.179960012891431
Revenue growth (%): 16.535937822834626
Rule of 40 score: 27.715897835726057
Financial ratios for NEWGEN.NS — quarterly report dated 2025-06-30
Total revenue: 37521214.60332319
Gross profit: 16281862.85981746
Operating income: 4205487.947577815
Net income: 5817996.723613387
Capital expenditures: 0
Depreciation & amortization: 1060074.8888368828
Owner earnings: 6878071.61245027
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 13.493798268195649
P/E ratio: 51.12329230480075
Shares outstanding: 141159509
Market cap (USD): 1904777938.083548
Effective tax rate (%): 22.44098909944031
Interest coverage ratio: 29.449442805637496
COGS to revenue (%): 56.60624787350195
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -25.33982669120631
Rule of 40 score: -25.33982669120631
Financial ratios for NEWGEN.NS — quarterly report dated 2025-12-31
Total revenue: 44589228.027180575
Gross profit: 23495533.02885151
Operating income: 10825554.194051465
Net income: 6997337.6406371845
Capital expenditures: 0
Depreciation & amortization: 1009691.4336638076
Owner earnings: 8007029.074300992
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.309791689874123
P/E ratio: 36.652198894595706
Shares outstanding: 141159509
Market cap (USD): 1314165623.8349113
Effective tax rate (%): 21.5332073336323
Interest coverage ratio: 46.73062127332179
COGS to revenue (%): 47.30670597273142
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 18.837379062967173
Rule of 40 score: 18.837379062967173
Financial ratios for NICE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 303.6
Shares outstanding: 58597188
Market cap (USD): 17790106276.800003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NICE — annual report dated 2022-12-31
Total revenue: 619685795.4545455
Gross profit: 425456250
Operating income: 95219602.27272727
Net income: 75552556.81818181
Capital expenditures: 9060511.363636363
Operating cash flow: 136282670.45454547
Depreciation & amortization: 50155113.63636363
Net tangible assets: 345273295.45454544
Owner earnings: 116647159.09090908
Return on net tangible assets (%): 33.78400838597882
Capex to operating income (%): 9.515384592434355
Buffett classification: The Great
Stock price: 192.3
P/E ratio: 149.14438011035367
Shares outstanding: 58597188
Book value: 868017897.7272727
P/B ratio: 12.981574783081754
Market cap (USD): 11268239252.400002
Debt to equity: 0.25445282044417417
Current ratio: 2.118031014259339
Quick ratio: 2.118031014259339
Effective tax rate (%): 22.98860227259565
Interest coverage ratio: 90.2458266020463
COGS to revenue (%): 31.34323021105821
R&D to revenue (%): 14.031716953331369
SG&A to revenue (%): 39.259265371838914
Free cash flow (dilution-adjusted): 61113920.45454545
Buyback yield (%): 0.3654277461183872
Retained earnings: 547272159.0909091
Receivables turnover: 4.199755095439616
Capitalized R&D asset: 86952556.81818181
ROCI (R&D-adjusted, %): 13.415893828281636
FCF margin (%): 9.862081865168106
Rule of 40 score: 9.862081865168106
Financial ratios for NICE — annual report dated 2023-12-31
Total revenue: 656770165.7458563
Gross profit: 444567679.55801105
Operating income: 120228453.03867403
Net income: 93453314.91712707
Capital expenditures: 8067679.558011049
Operating cash flow: 155091160.22099447
Depreciation & amortization: 46232044.19889503
Net tangible assets: 335265745.8563536
Owner earnings: 131617679.55801105
Return on net tangible assets (%): 39.257717552333354
Capex to operating income (%): 6.710291411148665
Buffett classification: The Great
Stock price: 199.51
P/E ratio: 125.09695336379613
Shares outstanding: 58597188
Book value: 926657458.5635358
P/B ratio: 12.616015626747831
Market cap (USD): 11690724977.88
Debt to equity: 0.23340766135042482
Current ratio: 2.0644815191360335
Quick ratio: 2.0644815191360335
Effective tax rate (%): 26.086738038016165
Interest coverage ratio: 117.59713590921373
COGS to revenue (%): 32.31000694845191
R&D to revenue (%): 13.573371782555519
SG&A to revenue (%): 35.810605053694886
Free cash flow (dilution-adjusted): 83036740.33149171
Buyback yield (%): 0.6815692516169408
Retained earnings: 625109944.7513812
Receivables turnover: 4.055257062349261
Capitalized R&D asset: 147404069.421773
ROCI (R&D-adjusted, %): 12.038248935064818
Rosenberg metric: 0.2197914616584897
FCF margin (%): 12.643196153283187
Revenue growth (%): 5.984382821637705
Rule of 40 score: 18.62757897492089
Financial ratios for NICE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 173.67
Shares outstanding: 58597188
Market cap (USD): 10176573639.96
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NICE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 169.84
Shares outstanding: 58597188
Market cap (USD): 9952146409.92
Buyback yield (%): 0
Retained earnings: 740382739.7260274
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NICE — annual report dated 2024-12-31
Total revenue: 749389589.0410959
Gross profit: 500204931.50684935
Operating income: 149576438.3561644
Net income: 121256986.30136986
Capital expenditures: 9578630.136986302
Operating cash flow: 228120821.91780823
Depreciation & amortization: 56169863.01369863
Net tangible assets: 413350136.98630136
Owner earnings: 167848219.17808217
Return on net tangible assets (%): 40.60678929535343
Capex to operating income (%): 6.4038362206339725
Buffett classification: The Great
Stock price: 169.84
P/E ratio: 82.0748289520005
Shares outstanding: 58597188
Book value: 987167945.2054794
P/B ratio: 10.081512936330665
Market cap (USD): 9952146409.92
Debt to equity: 0.15641895745488063
Current ratio: 1.698814587934
Quick ratio: 1.698814587934
Effective tax rate (%): 26.823912993158366
Interest coverage ratio: 3499.705128205128
COGS to revenue (%): 33.25168392759477
R&D to revenue (%): 13.18358832320881
SG&A to revenue (%): 33.604957751916444
Free cash flow (dilution-adjusted): 150906027.39726025
Buyback yield (%): 1.0163595356703459
Retained earnings: 740382739.7260274
Receivables turnover: 4.219854950161294
Capitalized R&D asset: 187218505.86307046
ROCI (R&D-adjusted, %): 12.699827849531925
Rosenberg metric: 0.6241148408307033
FCF margin (%): 20.13719293730203
Revenue growth (%): 14.1022580083334
Rule of 40 score: 34.239450945635426
Financial ratios for NICE — quarterly report dated 2025-03-31
Total revenue: 189753929.5392954
Gross profit: 126859620.59620596
Operating income: 40154200.54200542
Net income: 35037940.37940379
Capital expenditures: 993766.9376693767
Operating cash flow: 77255013.55013551
Depreciation & amortization: 11772628.726287263
Net tangible assets: 388479674.796748
Owner earnings: 45816802.16802168
Return on net tangible assets (%): 11.793873692875428
Capex to operating income (%): 2.474876661109949
Buffett classification: The Great
Stock price: 154.17
P/E ratio: 64.45818715467631
Shares outstanding: 58597188
Book value: 948481029.8102981
P/B ratio: 9.524627472799155
Market cap (USD): 9033928473.96
Debt to equity: 0.15390804581280296
Current ratio: 1.5963950493150827
Quick ratio: 1.5963950493150827
Effective tax rate (%): 21.17376645388644
COGS to revenue (%): 33.14519446094785
R&D to revenue (%): 12.725366756546775
SG&A to revenue (%): 32.968242996206754
Free cash flow (dilution-adjusted): 59973170.73170732
Buyback yield (%): 0.7569447003652575
Receivables turnover: 1.0885308086343461
Capitalized R&D asset: 24146883.468834687
ROCI (R&D-adjusted, %): 5.494934680967186
FCF margin (%): 31.60575956309127
Rule of 40 score: 31.60575956309127
Financial ratios for NICE — quarterly report dated 2025-06-30
Total revenue: 214369321.5339233
Gross profit: 143100589.97050148
Operating income: 47372271.38643067
Net income: 55281415.92920354
Capital expenditures: 1350737.4631268436
Operating cash flow: 18089085.54572271
Depreciation & amortization: 13159882.005899705
Net tangible assets: 493629793.5103245
Owner earnings: 67090560.47197639
Return on net tangible assets (%): 13.591270493395202
Capex to operating income (%): 2.85132509714058
Buffett classification: The Great
Stock price: 168.91
P/E ratio: 109.58504831745313
Shares outstanding: 58597188
Book value: 1100661946.9026546
P/B ratio: 8.99245318049991
Market cap (USD): 9897651025.08
Debt to equity: 0.14446495592354724
Current ratio: 1.8336852151781582
Quick ratio: 1.8336852151781582
Effective tax rate (%): -6.83647640982373
COGS to revenue (%): 33.24576998866126
R&D to revenue (%): 12.351798236440295
SG&A to revenue (%): 32.303993879280924
Free cash flow (dilution-adjusted): 382300.88495575264
Buyback yield (%): 0.09191120321823124
Receivables turnover: 1.0671827984780378
Capitalized R&D asset: 42656878.00081541
ROCI (R&D-adjusted, %): 4.744172588618769
Rosenberg metric: 0.6725907049353602
FCF margin (%): 0.17833749821112097
Revenue growth (%): 12.972269957408386
Rule of 40 score: 13.150607455619507
Financial ratios for NICE — quarterly report dated 2025-09-30
Total revenue: 221147734.13897282
Gross profit: 147754984.8942598
Operating income: 48572205.43806647
Net income: 43762235.649546824
Capital expenditures: 2192749.2447129907
Operating cash flow: 57552870.09063444
Depreciation & amortization: 14778851.963746224
Net tangible assets: 241183685.80060422
Owner earnings: 56348338.36858006
Return on net tangible assets (%): 23.36324622518846
Capex to operating income (%): 4.51441153420329
Buffett classification: The Great
Stock price: 144.78
P/E ratio: 63.272674158639894
Shares outstanding: 58597188
Book value: 1166388519.6374621
P/B ratio: 7.273477692730473
Market cap (USD): 8483700878.64
Debt to equity: 0.02249668846383575
Current ratio: 1.410850040194402
Quick ratio: 1.410850040194402
Effective tax rate (%): 20.371062613380243
COGS to revenue (%): 33.18720380765547
R&D to revenue (%): 12.358350216325432
SG&A to revenue (%): 32.490754768790666
Free cash flow (dilution-adjusted): 38593655.58912387
Buyback yield (%): 0.14440699379981706
Receivables turnover: 1.023896547141968
Capitalized R&D asset: 53039255.29646442
ROCI (R&D-adjusted, %): 3.801055603785538
Rosenberg metric: 0.17578038358704945
FCF margin (%): 17.451526573123733
Revenue growth (%): 3.162025497187039
Rule of 40 score: 20.61355207031077
Financial ratios for NICE — quarterly report dated 2025-12-31
Total revenue: 247325786.163522
Gross profit: 161588993.7106918
Operating income: 55416037.73584905
Net income: 47344025.1572327
Capital expenditures: 1074213.8364779875
Operating cash flow: 56495597.48427673
Depreciation & amortization: 19519811.320754714
Net tangible assets: 266791509.43396226
Owner earnings: 65789622.64150943
Return on net tangible assets (%): 24.659563859843917
Capex to operating income (%): 1.9384529828682977
Buffett classification: The Great
Stock price: 113.04
P/E ratio: 36.50987240300933
Shares outstanding: 58597188
Book value: 1219033962.2641509
P/B ratio: 5.433668245975162
Market cap (USD): 6623826131.52
Debt to equity: 0.022907354209746454
Current ratio: 1.5537292128337692
Quick ratio: 1.5537292128337692
Effective tax rate (%): 17.584138036742647
COGS to revenue (%): 34.66552913174383
R&D to revenue (%): 11.58594576450484
SG&A to revenue (%): 31.342435307999022
Free cash flow (dilution-adjusted): 39752515.72327044
Buyback yield (%): 0.7842471825177602
Retained earnings: 1042294968.553459
Receivables turnover: 1.0508414791220184
Capitalized R&D asset: 55704166.94369351
ROCI (R&D-adjusted, %): 4.093567031920178
Rosenberg metric: 0.5061800866916851
FCF margin (%): 16.072936162421676
Revenue growth (%): 11.83735936814911
Rule of 40 score: 27.910295530570785
Financial ratios for NICE — annual report dated 2025-12-31
Total revenue: 926226100.6289308
Gross profit: 615139937.1069182
Operating income: 203068553.4591195
Net income: 192484591.19496855
Capital expenditures: 5949685.534591194
Operating cash flow: 225329874.21383646
Depreciation & amortization: 62592452.83018868
Net tangible assets: 266791509.43396226
Owner earnings: 249127358.49056602
Return on net tangible assets (%): 93.37904306592314
Capex to operating income (%): 2.929890144605254
Buffett classification: The Great
Stock price: 113.04
P/E ratio: 34.41224095081302
Shares outstanding: 58597188
Book value: 1219033962.2641509
P/B ratio: 5.433668245975162
Market cap (USD): 6623826131.52
Debt to equity: 0.022907354209746454
Current ratio: 1.5537292128337692
Quick ratio: 1.5537292128337692
Effective tax rate (%): 13.055934728848879
COGS to revenue (%): 33.58641732410448
R&D to revenue (%): 12.237730779429205
SG&A to revenue (%): 32.25155573149851
Free cash flow (dilution-adjusted): 149922955.97484273
Buyback yield (%): 2.321099534190158
Retained earnings: 1042294968.553459
Receivables turnover: 3.9353632335886184
Capitalized R&D asset: 208960802.8990888
ROCI (R&D-adjusted, %): 14.066218829946632
Rosenberg metric: 1.1633517109769123
FCF margin (%): 16.186431787340183
Revenue growth (%): 23.59740703285076
Rule of 40 score: 39.783838820190944
Financial ratios for NOEM — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -170720
Net income: 406402
Capital expenditures: 0
Operating cash flow: -337343
Net tangible assets: 68375759
Owner earnings: 406402
Return on net tangible assets (%): 0.5943656142815175
Buffett classification: The Gruesome
Stock price: 9.92
P/E ratio: 58.49543063272326
Shares outstanding: 9585750
Book value: 68375759
P/B ratio: 1.3907069024272183
Market cap (USD): 95090640
Debt to equity: 0.00017155202620858657
Current ratio: 1.9206272147029182
Quick ratio: 1.9206272147029182
Effective tax rate (%): 26.432158256972077
Interest coverage ratio: -65.03619047619047
Free cash flow (dilution-adjusted): -337343
Buyback yield (%): 0
Retained earnings: -1469071
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.24234248082982537
Rule of 40 score: 0
Financial ratios for NOEM — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -162313
Net income: 418891
Capital expenditures: 0
Operating cash flow: -226329
Net tangible assets: 68794650
Owner earnings: 418891
Return on net tangible assets (%): 0.608900546772169
Buffett classification: The Gruesome
Stock price: 10.07
P/E ratio: 116.96270597230317
Shares outstanding: 9585750
Book value: 68794650
P/B ratio: 1.4031396700179448
Market cap (USD): 96528502.5
Debt to equity: 0.00017050744498300376
Current ratio: 1.29455962182167
Quick ratio: 1.29455962182167
Effective tax rate (%): 25.944017495195716
Interest coverage ratio: -97.95594447797224
Free cash flow (dilution-adjusted): -226329
Buyback yield (%): 0
Retained earnings: -1538034
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.22904649920658607
Rule of 40 score: 0
Financial ratios for NOEM — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -154489
Net income: 434805
Capital expenditures: 0
Operating cash flow: -125789
Net tangible assets: 69229455
Owner earnings: 434805
Return on net tangible assets (%): 0.6280635894071389
Buffett classification: The Gruesome
Stock price: 10.2
P/E ratio: 77.59289356859544
Shares outstanding: 9585750
Book value: 69229455
P/B ratio: 1.4123273106801144
Market cap (USD): 97774650
Debt to equity: 0.0001694365498038371
Current ratio: 0.7851940597653007
Quick ratio: 0.7851940597653007
Effective tax rate (%): 25.462468521626434
Interest coverage ratio: -230.9252615844544
Free cash flow (dilution-adjusted): -125789
Buyback yield (%): 0
Retained earnings: -1661991
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.21667627052689253
Rule of 40 score: 0
Financial ratios for NOEM — annual report dated 2025-12-31
Total revenue: 0
Operating income: -646306
Net income: 1652360
Capital expenditures: 0
Operating cash flow: -745359
Net tangible assets: 69621718
Owner earnings: 1652360
Return on net tangible assets (%): 2.373339882247663
Buffett classification: The Gruesome
Stock price: 10.29
P/E ratio: 59.69484101527511
Shares outstanding: 9585750
Book value: 69621718
P/B ratio: 1.41676146945986
Market cap (USD): 98637367.49999999
Debt to equity: 0.00016848190962480988
Current ratio: 0.4756288263357475
Quick ratio: 0.4756288263357475
Effective tax rate (%): 25.957326297525757
Interest coverage ratio: -130.54049686931933
Free cash flow (dilution-adjusted): -745359
Buyback yield (%): 0
Retained earnings: -1788774
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.901507200594635
Rule of 40 score: 0
Financial ratios for NOEM — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -158784
Net income: 392262
Capital expenditures: 0
Operating cash flow: -55898
Net tangible assets: 69621718
Owner earnings: 392262
Return on net tangible assets (%): 0.5634190181862504
Buffett classification: The Gruesome
Stock price: 10.29
P/E ratio: 59.69484101527511
Shares outstanding: 9585750
Book value: 69621718
P/B ratio: 1.41676146945986
Market cap (USD): 98637367.49999999
Debt to equity: 0.00016848190962480988
Current ratio: 0.4756288263357475
Quick ratio: 0.4756288263357475
Effective tax rate (%): 26.021243370876363
Free cash flow (dilution-adjusted): -55898
Buyback yield (%): 0
Retained earnings: -1788774
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.22148165008404455
Rule of 40 score: 0
Financial ratios for NTX.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.0962962962962963
Shares outstanding: 82851568
Market cap (USD): 7978299.140740741
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NTX.V — annual report dated 2024-12-31
Total revenue: 0
Operating income: -2257741.958041958
Net income: -1836546.153846154
Capital expenditures: 0
Operating cash flow: -2114192.307692308
Net tangible assets: 2785661.5384615385
Owner earnings: -1836546.153846154
Return on net tangible assets (%): -65.92854618154506
Buffett classification: The Gruesome
Stock price: 0.06993006993006994
Shares outstanding: 82851568
Book value: 2785661.538461539
P/B ratio: 2.0798707467008875
Market cap (USD): 5793815.944055945
Debt to equity: 0
Current ratio: 16.176263515212472
Quick ratio: 16.176263515212472
Free cash flow (dilution-adjusted): -2645660.8391608396
Buyback yield (%): 0
Retained earnings: -4173408.391608392
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -81.04868186135997
Rule of 40 score: 0
Financial ratios for NTX.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -404247.55244755244
Net income: -332777.6223776224
Capital expenditures: 0
Operating cash flow: -539093.006993007
Net tangible assets: 2785661.5384615385
Owner earnings: -332777.6223776224
Return on net tangible assets (%): -11.94608956554745
Buffett classification: The Gruesome
Stock price: 0.06993006993006994
Shares outstanding: 82851568
Book value: 2785661.538461539
P/B ratio: 2.0798707467008875
Market cap (USD): 5793815.944055945
Debt to equity: 0
Current ratio: 16.176263515212472
Quick ratio: 16.176263515212472
Free cash flow (dilution-adjusted): -539093.006993007
Buyback yield (%): 0
Retained earnings: -4173408.391608392
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.511725378913393
Rule of 40 score: 0
Financial ratios for NTX.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -178188.1118881119
Net income: -158074.82517482518
Capital expenditures: 0
Operating cash flow: -99500
Net tangible assets: 2627586.713286713
Owner earnings: -158074.82517482518
Return on net tangible assets (%): -6.015969877435463
Buffett classification: The Gruesome
Stock price: 0.05594405594405595
Shares outstanding: 82851568
Book value: 2627586.7132867137
P/B ratio: 1.7639961154496044
Market cap (USD): 4635052.755244756
Debt to equity: 0
Current ratio: 35.78088899585308
Quick ratio: 35.78088899585308
Free cash flow (dilution-adjusted): -99500
Buyback yield (%): 0
Retained earnings: -4331483.216783217
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.7814360221522625
Rule of 40 score: 0
Financial ratios for NTX.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -323109.48905109486
Net income: -305394.8905109489
Capital expenditures: 0
Operating cash flow: -187356.93430656934
Net tangible assets: 2437268.613138686
Owner earnings: -305394.8905109489
Return on net tangible assets (%): -12.530210616287588
Buffett classification: The Gruesome
Stock price: 0.16058394160583941
Shares outstanding: 82851568
Book value: 2437268.613138686
P/B ratio: 5.458828495941071
Market cap (USD): 13304631.357664233
Debt to equity: 0
Current ratio: 7.454531044614551
Quick ratio: 7.454531044614551
Free cash flow (dilution-adjusted): -187356.93430656934
Buyback yield (%): 0
Retained earnings: -4826578.10218978
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.257032372603291
Rule of 40 score: 0
Financial ratios for NTX.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -226358.9928057554
Net income: -213418.70503597124
Capital expenditures: 0
Operating cash flow: -544490.6474820144
Net tangible assets: 2188781.294964029
Owner earnings: -213418.70503597124
Return on net tangible assets (%): -9.750572408810658
Buffett classification: The Gruesome
Stock price: 0.1654676258992806
Shares outstanding: 82851568
Book value: 2188781.294964029
P/B ratio: 6.26341804479744
Market cap (USD): 13709252.258992808
Debt to equity: 0
Current ratio: 21.482892805687584
Quick ratio: 21.482892805687584
Free cash flow (dilution-adjusted): -544490.6474820144
Buyback yield (%): 0
Retained earnings: -4970549.64028777
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.341782129012367
Rule of 40 score: 0
Financial ratios for NTX.V — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -436383.2116788321
Net income: -422330.65693430655
Capital expenditures: 0
Operating cash flow: 92651.82481751824
Net tangible assets: 2133983.9416058394
Owner earnings: -422330.65693430655
Return on net tangible assets (%): -19.79071391776732
Buffett classification: The Gruesome
Stock price: 0.16058394160583941
Shares outstanding: 82851568
Book value: 2133983.9416058394
P/B ratio: 6.234644552972782
Market cap (USD): 13304631.357664233
Debt to equity: 0
Current ratio: 5.802922274208811
Quick ratio: 5.802922274208811
Free cash flow (dilution-adjusted): 92651.82481751824
Buyback yield (%): 0
Retained earnings: -5465443.065693431
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.44922659307597
Rule of 40 score: 0
Financial ratios for NTX.V — annual report dated 2025-12-31
Total revenue: 0
Operating income: -1175148.1751824818
Net income: -1109257.6642335765
Capital expenditures: 0
Operating cash flow: -751002.1897810218
Net tangible assets: 2133983.9416058394
Owner earnings: -1109257.6642335765
Return on net tangible assets (%): -51.980600350668595
Buffett classification: The Gruesome
Stock price: 0.16058394160583941
Shares outstanding: 82851568
Book value: 2133983.9416058394
P/B ratio: 6.234644552972782
Market cap (USD): 13304631.357664233
Debt to equity: 0
Current ratio: 5.802922274208811
Quick ratio: 5.802922274208811
Free cash flow (dilution-adjusted): -751002.1897810218
Buyback yield (%): 0
Retained earnings: -5465443.065693431
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -55.06827639472177
Rule of 40 score: 0
Financial ratios for OBE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.12
Shares outstanding: 66776768
Market cap (USD): 275120284.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OBE — annual report dated 2022-12-31
Total revenue: 676470588.2352941
Gross profit: 640441176.4705882
Operating income: 454779411.76470584
Net income: 595661764.7058823
Capital expenditures: 3382352.9411764704
Operating cash flow: 335882352.9411765
Depreciation & amortization: -81985294.11764705
Net tangible assets: 1161544117.6470587
Owner earnings: 510294117.6470588
Return on net tangible assets (%): 43.932392226372095
Capex to operating income (%): 0.7437348423605498
Buffett classification: The Great
Stock price: 6.64
P/E ratio: 0.7443783801347983
Shares outstanding: 66776768
Book value: 1161544117.6470587
P/B ratio: 0.38173129438956765
Market cap (USD): 443397739.52
Debt to equity: 0.14642020636829778
Current ratio: 0.44997756841633024
Quick ratio: 0.44997756841633024
Effective tax rate (%): -43.71119389746319
Interest coverage ratio: 19.57278481012658
COGS to revenue (%): 5.326086956521739
SG&A to revenue (%): 5.054347826086956
Free cash flow (dilution-adjusted): 97573529.41176471
Buyback yield (%): 0
Retained earnings: -546617647.0588235
Receivables turnover: 11.138014527845037
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 31.215302311496924
FCF margin (%): 14.423913043478262
Rule of 40 score: 14.423913043478262
Financial ratios for OBE — annual report dated 2023-12-31
Total revenue: 569015151.5151515
Gross profit: 324469696.96969694
Operating income: 110075757.57575758
Net income: 81818181.81818181
Capital expenditures: 454545.45454545453
Operating cash flow: 267196969.6969697
Depreciation & amortization: 159848484.84848484
Net tangible assets: 1245303030.3030303
Owner earnings: 241212121.2121212
Return on net tangible assets (%): 19.369753011315243
Capex to operating income (%): 0.4129387474191328
Buffett classification: The Great
Stock price: 6.78
P/E ratio: 5.533568174933333
Shares outstanding: 66776768
Book value: 1245303030.3030303
P/B ratio: 0.3635633062980898
Market cap (USD): 452746487.04
Debt to equity: 0.13870300523178003
Current ratio: 0.41130434782608694
Quick ratio: 0.41130434782608694
Effective tax rate (%): 24.79108635097493
Interest coverage ratio: 5.0103448275862075
COGS to revenue (%): 42.976967114898144
SG&A to revenue (%): 4.6864598588736515
Free cash flow (dilution-adjusted): 39090909.090909086
Buyback yield (%): 7.931390289488507
Retained earnings: -481363636.3636363
Receivables turnover: 10.73
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.191645218768561
FCF margin (%): 6.869924111303422
Revenue growth (%): -15.88471673254282
Rule of 40 score: -9.014792621239398
Financial ratios for OBE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.54
Shares outstanding: 66776768
Market cap (USD): 369943294.72
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OBE — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 279720.27972027974
Buffett classification: The Gruesome
Stock price: 5.79
Shares outstanding: 66776768
Market cap (USD): 386637486.72
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for OBE — annual report dated 2024-12-31
Total revenue: 585804195.8041959
Gross profit: 43566433.56643357
Operating income: -174475524.4755245
Net income: -141678321.6783217
Capital expenditures: 58321678.321678326
Operating cash flow: 253076923.0769231
Depreciation & amortization: 172797202.7972028
Net tangible assets: 983076923.0769231
Owner earnings: -27202797.20279722
Return on net tangible assets (%): -2.767107696685163
Buffett classification: The Gruesome
Stock price: 5.79
Shares outstanding: 66776768
Book value: 983076923.0769231
P/B ratio: 0.3932932181032864
Market cap (USD): 386637486.72
Debt to equity: 0.24363351828140561
Current ratio: 1.7875045405012715
Quick ratio: 1.7875045405012715
Interest coverage ratio: -7.4924924924924925
COGS to revenue (%): 92.56297003700608
SG&A to revenue (%): 3.4260475110421384
Free cash flow (dilution-adjusted): -50909090.909090914
Buyback yield (%): 7.542165507080596
Retained earnings: -586013986.013986
Receivables turnover: 9.519318181818182
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.564943184907301
FCF margin (%): -8.690461979228841
Revenue growth (%): 2.950544329854691
Rule of 40 score: -5.73991764937415
Financial ratios for OBE — quarterly report dated 2025-03-31
Total revenue: 150909090.9090909
Gross profit: 91188811.1888112
Operating income: 29020979.02097902
Net income: 10769230.76923077
Capital expenditures: 0
Operating cash flow: 67622377.62237762
Depreciation & amortization: 38671328.67132867
Net tangible assets: 987272727.2727274
Owner earnings: 49440559.44055944
Return on net tangible assets (%): 5.007791471879869
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.86
P/E ratio: 9.084025332571429
Shares outstanding: 66776768
Book value: 987272727.2727273
P/B ratio: 0.3963563964346225
Market cap (USD): 391311860.48
Debt to equity: 0.25286867828304294
Current ratio: 1.5637348629700445
Quick ratio: 1.5637348629700445
Effective tax rate (%): 24.509803921568626
Interest coverage ratio: 5.3896103896103895
COGS to revenue (%): 39.57367933271548
SG&A to revenue (%): 3.9388322520852648
Free cash flow (dilution-adjusted): -23636363.636363637
Buyback yield (%): 1.7155847780979363
Retained earnings: -575244755.2447553
Receivables turnover: 2.509302325581395
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2315427219443995
FCF margin (%): -15.66265060240964
Rule of 40 score: -15.66265060240964
Financial ratios for OBE — quarterly report dated 2025-06-30
Total revenue: 102335766.42335765
Gross profit: 55839416.05839416
Operating income: 12773722.627737226
Net income: 11167883.21167883
Capital expenditures: 153941605.83941606
Operating cash flow: 40291970.80291971
Depreciation & amortization: 34087591.24087591
Net tangible assets: 1016350364.9635036
Owner earnings: -108686131.38686132
Return on net tangible assets (%): -10.693766159149671
Capex to operating income (%): 1205.142857142857
Buffett classification: The Gruesome
Stock price: 5.55
P/E ratio: 16.89424883886358
Shares outstanding: 66776768
Book value: 1016350364.9635036
P/B ratio: 0.36464891948290723
Market cap (USD): 370611062.4
Debt to equity: 0.1632433208848032
Current ratio: 0.7979846449136275
Quick ratio: 0.7979846449136275
Effective tax rate (%): 21.938775510204085
Interest coverage ratio: 3.30188679245283
COGS to revenue (%): 45.43509272467903
SG&A to revenue (%): 3.4236804564907275
Free cash flow (dilution-adjusted): 9197080.291970802
Buyback yield (%): 7.2084541389969266
Retained earnings: -589270072.9927007
Receivables turnover: 2.058737151248164
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.0582970488630865
FCF margin (%): 8.98716119828816
Revenue growth (%): -32.18714273150999
Rule of 40 score: -23.199981533221827
Financial ratios for OBE — quarterly report dated 2025-09-30
Total revenue: 94100719.42446044
Gross profit: 49928057.55395684
Operating income: 1654676.2589928058
Net income: 12086330.935251798
Capital expenditures: 215827.3381294964
Operating cash flow: 32661870.503597125
Depreciation & amortization: 32086330.935251802
Net tangible assets: 1009352517.9856116
Owner earnings: 43956834.53237411
Return on net tangible assets (%): 4.354953670705631
Capex to operating income (%): 13.043478260869565
Buffett classification: The Great
Stock price: 6.54
P/E ratio: 12.835856680478425
Shares outstanding: 66776768
Book value: 1009352517.9856117
P/B ratio: 0.4326734762514611
Market cap (USD): 436720062.72
Debt to equity: 0.10662865288667141
Current ratio: 0.5247933884297521
Quick ratio: 0.5247933884297521
Effective tax rate (%): 2.3255813953488373
Interest coverage ratio: 0.48936170212765956
COGS to revenue (%): 46.94189602446483
SG&A to revenue (%): 9.250764525993885
Free cash flow (dilution-adjusted): -15755395.68345324
Buyback yield (%): 1.4331818801208374
Retained earnings: -568705035.9712231
Receivables turnover: 2.147783251231527
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.1407674888304058
FCF margin (%): -16.743119266055047
Revenue growth (%): -8.047085869107832
Rule of 40 score: -24.79020513516288